搜索优化
English
搜索
Copilot
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
房地产
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
过去 7 天
时间不限
过去 1 小时
过去 24 小时
过去 30 天
按相关度排序
按时间排序
BioSpace
2 天
Merck Touts 100% Complete Response Rate for Anti-ROR1 ADC as First-Line Lymphoma Treatment
Analysts called the data “very competitive” but raised questions about safety. Merck gained ownership of the ADC when it ...
North Bay Nugget
5 小时
Month to go before addictions treatment centre on Lakeshore Drive is complete
The building is slated to be ready for occupancy in a month. The secured entrance offers a large receptionist area. A few ...
The Tablet
1 天
Archbishop of Liverpool declares Lourdes cure miraculous, 101 years later
The Archbishop of Liverpool Malcolm McMahon formally recognised the cure of John Traynor during the archdiocese’s first ...
News Medical
9 小时
Prostate cancer vaccines: Progress, challenges, and future directions
Prostate cancer vaccines, including dendritic and peptide types, offer hope for improved treatments, but face hurdles in ...
3 小时
Predictors for radiotherapy success may help some rectal cancer patients avoid surgery
CORT team has identified key biomarkers and treatment strategies that predict and enhance effectiveness of radiotherapy in ...
Medscape
2 天
Epcore NHL-1 Update: Treatment Effective Before CAR T
A subgroup analysis showed that epcoritamab is effective regardless of CAR T–exposure in patients with R/R LBCL.
BlackDoctor
1 小时
A New Hope for Hard-to-Treat Bladder Cancer Made It Through Clinical Trials
There may be an effective new treatment for people with bladder cancer that doesn't respond to a frontline therapy.
Cure Today
1 天
Uproleselan Fails to Improve Survival in AML, Although Some Subgroups May Benefit
A Phase 3 trial of uproleselan failed to improve overall survival in relapsed/refractory AML, though it may benefit primary ...
1 天
Unmet needs in the chronic hand eczema treatment landscape
Chronic exposure to irritants, allergens, and repetitive hand washing are established risk factors for chronic hand eczema.
1 天
on MSN
Treatment method does not improve survival for mantle cell lymphoma patients, clinical ...
Late-breaking research reveals there is no benefit from high-dose chemotherapy followed by autologous stem cell transplant ...
Targeted Oncology
2 小时
Phase 2 Trial Highlights 100% Complete Response with Cilta-Cel in Smoldering Myeloma
Ciltacabtagene autoleucel achieved a 100% complete response rate in patients with high-risk smoldering multiple myeloma, as ...
1 天
Protara: Six-Month NMIBC Treatment Data Bodes Well For Mid-2025 Catalyst
Stay updated on the latest advancements in bladder cancer treatment and the financial decisions of a leading company in the ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
反馈